NO169492C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2',3'-dideoksy-2'-fluornukleosider - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 2',3'-dideoksy-2'-fluornukleosider

Info

Publication number
NO169492C
NO169492C NO884995A NO884995A NO169492C NO 169492 C NO169492 C NO 169492C NO 884995 A NO884995 A NO 884995A NO 884995 A NO884995 A NO 884995A NO 169492 C NO169492 C NO 169492C
Authority
NO
Norway
Prior art keywords
dideoxy
preparation
fluornucleosides
therapeutic active
analogy procedure
Prior art date
Application number
NO884995A
Other languages
English (en)
Norwegian (no)
Other versions
NO169492B (no
NO884995L (no
NO884995D0 (no
Inventor
Roman Z Sterzycki
Muzammil M Mansuri
John C Martin
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO884995D0 publication Critical patent/NO884995D0/no
Publication of NO884995L publication Critical patent/NO884995L/no
Publication of NO169492B publication Critical patent/NO169492B/no
Publication of NO169492C publication Critical patent/NO169492C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO884995A 1987-11-12 1988-11-09 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2',3'-dideoksy-2'-fluornukleosider NO169492C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/120,051 US4908440A (en) 1987-11-12 1987-11-12 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Publications (4)

Publication Number Publication Date
NO884995D0 NO884995D0 (no) 1988-11-09
NO884995L NO884995L (no) 1989-05-16
NO169492B NO169492B (no) 1992-03-23
NO169492C true NO169492C (no) 1993-01-12

Family

ID=22387985

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884995A NO169492C (no) 1987-11-12 1988-11-09 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2',3'-dideoksy-2'-fluornukleosider

Country Status (22)

Country Link
US (4) US4908440A (es)
EP (1) EP0316017B1 (es)
JP (4) JPH01153698A (es)
KR (1) KR920004459B1 (es)
AT (1) ATE100461T1 (es)
AU (1) AU615960B2 (es)
CA (1) CA1340961C (es)
CZ (3) CZ278366B6 (es)
DD (1) DD275874A5 (es)
DE (1) DE3887273T2 (es)
DK (1) DK173971B1 (es)
ES (1) ES2061609T3 (es)
FI (1) FI90244C (es)
HU (1) HU199499B (es)
IE (1) IE62227B1 (es)
IL (1) IL88330A (es)
NO (1) NO169492C (es)
NZ (1) NZ226845A (es)
PT (1) PT88994B (es)
SK (2) SK277919B6 (es)
YU (1) YU47121B (es)
ZA (1) ZA888313B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5495010A (en) * 1987-04-17 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services Acid stable purine dideoxynucleosides
US5459256A (en) * 1987-04-17 1995-10-17 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Lipophilic, aminohydrolase-activated prodrugs
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US5644043A (en) * 1988-02-16 1997-07-01 Eli Lilly And Company 2',3'-dideoxy-2',2'-difluoronucleosides and intermediates
US5198539A (en) * 1988-08-19 1993-03-30 Burroughs Wellcome Co. 5'-esters of 2',3'-dideoxy-3'-fluoro-5-ethynyluridine
GR1000618B (el) * 1989-03-17 1992-08-31 Oncogen Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων.
FI95384C (fi) * 1989-04-06 1996-01-25 Squibb Bristol Myers Co Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
ES2253732T3 (es) * 1989-09-15 2006-06-01 Southern Research Institute 2'-deoxi-4'-tioribonucleosidos como agentes antivirales y anticancerosos.
US5817799A (en) * 1990-07-23 1998-10-06 The United States Of America As Represented By The Department Of Health And Human Services 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
US5420115A (en) * 1990-09-10 1995-05-30 Burroughs Wellcome Co. Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides
AU1254892A (en) * 1990-12-18 1992-07-22 Sloan-Kettering Institute For Cancer Research Novel synthesis of 2'-"up" fluorinated 2''-deoxy-arabinofuranosylpurines
US5712477A (en) * 1996-05-14 1998-01-27 Allen-Bradley Company, Inc. System to provide alignment and troubleshooting aid photoelectric sensors through alternating numeric display
CN101089010B (zh) * 1998-02-25 2011-12-14 埃莫里大学 2＇-氟代核苷
ES2276515T3 (es) 1998-02-25 2007-06-16 Emory University 2'-fluoronucleosidos.
EP1411954B1 (en) 2000-10-18 2010-12-15 Pharmasset, Inc. Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
AU2002322325A1 (en) 2001-06-22 2003-01-08 Emory University Beta-2'-or 3'-halonucleosides
US7160537B2 (en) * 2003-12-15 2007-01-09 Siemens Medical Solutions Usa, Inc. Method for preparing radiolabeled thymidine having low chromophoric byproducts
US20050131224A1 (en) * 2003-12-15 2005-06-16 Cti Pet Systems, Inc. Method for preparing radiolabeled thymidine
US8895531B2 (en) 2006-03-23 2014-11-25 Rfs Pharma Llc 2′-fluoronucleoside phosphonates as antiviral agents
US20070243798A1 (en) * 2006-04-18 2007-10-18 3M Innovative Properties Company Embossed structured abrasive article and method of making and using the same
KR20160076373A (ko) 2014-12-22 2016-06-30 김기범 양식용 패각 고정을 위한 로프 어셈블리

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE292023C (es) *
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
JPH01100190A (ja) * 1987-10-12 1989-04-18 Asahi Glass Co Ltd ヌクレオシド類
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
DK631688D0 (da) 1988-11-11
EP0316017A3 (en) 1990-05-30
DE3887273T2 (de) 1994-05-19
HUT48266A (en) 1989-05-29
SK278017B6 (en) 1995-10-11
IE62227B1 (en) 1995-01-11
DE3887273D1 (de) 1994-03-03
ZA888313B (en) 1989-07-26
IL88330A0 (en) 1989-06-30
NO169492B (no) 1992-03-23
NZ226845A (en) 1991-10-25
PT88994B (pt) 1995-03-31
SK743188A3 (en) 1995-08-09
KR890008161A (ko) 1989-07-10
NO884995L (no) 1989-05-16
KR920004459B1 (ko) 1992-06-05
ES2061609T3 (es) 1994-12-16
DK631688A (da) 1989-05-13
PT88994A (pt) 1989-09-14
JPH0648947A (ja) 1994-02-22
DD275874A5 (de) 1990-02-07
JPH0649091A (ja) 1994-02-22
YU47121B (sh) 1994-12-28
NO884995D0 (no) 1988-11-09
SK545290A3 (en) 1995-10-11
HU199499B (en) 1990-02-28
CZ743188A3 (en) 1993-08-11
JP2699050B2 (ja) 1998-01-19
FI885153A0 (fi) 1988-11-09
AU2504288A (en) 1989-05-25
CZ545190A3 (en) 1993-08-11
ATE100461T1 (de) 1994-02-15
FI90244B (fi) 1993-09-30
DK173971B1 (da) 2002-03-18
FI90244C (fi) 1994-01-10
JPH01153698A (ja) 1989-06-15
CA1340961C (en) 2000-04-18
CZ278394B6 (en) 1993-12-15
JPH09183731A (ja) 1997-07-15
US5126506A (en) 1992-06-30
CZ278366B6 (en) 1993-12-15
YU204888A (en) 1990-04-30
IE883406L (en) 1989-05-12
US5218106A (en) 1993-06-08
FI885153A (fi) 1989-05-13
US4973677A (en) 1990-11-27
US4908440A (en) 1990-03-13
IL88330A (en) 1995-03-15
EP0316017A2 (en) 1989-05-17
CZ278395B6 (en) 1993-12-15
CZ545290A3 (en) 1993-08-11
JP2811561B2 (ja) 1998-10-15
AU615960B2 (en) 1991-10-17
SK277919B6 (en) 1995-08-09
EP0316017B1 (en) 1994-01-19
JP2699049B2 (ja) 1998-01-19

Similar Documents

Publication Publication Date Title
NO169492C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2',3'-dideoksy-2'-fluornukleosider
NO171787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-azabicyclo(3.2.1)oct-2-en-forbindelser
NO171633C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cykloalkano(1.2-b)indol-sulfonamider
NO170155C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO166281C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater.
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO168107C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
NO164542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)-pyrimidinderivater.
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO168037C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.
NO167028C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)pyrimidinderivater
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
NO167668C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive epipodofyllotoksinglukosid-4'-acylderivater.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO171499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivater
NO167511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.
NO880639D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner.
NO170545C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6,21-dimethyl-19-nor-pregna-diener
NO164657C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinoner.
NO170017C (no) Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater
NO170541C (no) Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater
NO921307D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,5-tritianderivater
NO901627D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive anellerte di-hydropyridiner.